a Study of QL1706 or QL1604 in Patients With Limited-stage Small Cell Lung Cancer After Chemoradiotherapy.
Clinical trial NCT06789796 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06789796
- Sponsor
- Qilu Pharmaceutical Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-01
- Primary completion
- 2028-03-01
- Enrollment
- 636
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.